Predicting Survival of Brain Metastases in NSCLC with Updated Index
Significant prognostic factors include four factors from earlier index, as well as EGFR and ALK alterations.
Significant prognostic factors include four factors from earlier index, as well as EGFR and ALK alterations.
According to this randomized trial, there was limited clinical benefit for patients with brain metastases after receiving whole brain radiotherapy.